UnknownNot Applicable

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

China300 participantsStarted 2019-03-01

Plain-language summary

This was a prospective, cohort study.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult Patients * Receiving ECMO surpport for any reason Exclusion Criteria: * The duration of ECMO surpport was less than 24 hours . * Those who had difficulty in compliance or were unavailable for follow-up.

What they're measuring

Thrombotic events

Timeframe: 24 months

hemorrhagic events

Timeframe: 24 months

Trial details

NCT IDNCT03261284

SponsorWuhan Asia Heart Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Extracorporeal Membrane Oxygenation Complication trials